Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III
Clinical trial NCT02631928 · COMPLETED
Trial details
- NCT number
- NCT02631928
- Sponsor
- Julphar Gulf Pharmaceutical Industries
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.